Should clinicians be extra vigilant when deciding who receives antiviral therapy, or are the adverse effects few and infrequent?
Desirae Lindquist, PharmD, BCPS
Advertisement
Articles by Desirae Lindquist, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
2
A Closer Look at IDSA/ESCMID 2026 Consensus Statements 6 and 7 on Staphylococcus aureus Bacteremia
3
AI-Designed Phage Treatment of Resistant Bacterial Infection
4
Measles Update: October 30, 2026
5